Conmed (CNMD) Misses Q4 EPS by 48c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $0.42, $0.48 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $250.9 million versus the consensus estimate of $302.51 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- AllianceBernstein (AB) Tops Q3 EPS by 2c
- Centene (CNC) Tops Q3 EPS by 48c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
